Equities analysts expect that Markel Co. (NYSE:MKL) will report $1.58 billion in sales for the current quarter, Zacks reports. Three analysts have issued estimates for Markel’s earnings, with estimates ranging from $1.54 billion to $1.66 billion. Markel posted sales of $1.43 billion during the same quarter last year, which suggests a positive year over year growth rate of 10.5%. The business is scheduled to issue its next earnings results on Wednesday, February 14th.
According to Zacks, analysts expect that Markel will report full-year sales of $1.58 billion for the current fiscal year, with estimates ranging from $5.93 billion to $6.06 billion. For the next financial year, analysts expect that the firm will report sales of $6.39 billion per share, with estimates ranging from $6.12 billion to $6.81 billion. Zacks’ sales averages are an average based on a survey of analysts that follow Markel.
MKL has been the subject of several analyst reports. SunTrust Banks reiterated a “hold” rating and issued a $1,100.00 target price on shares of Markel in a report on Friday, October 27th. Royal Bank of Canada reiterated a “hold” rating and issued a $1,050.00 target price on shares of Markel in a report on Tuesday, October 3rd. Boenning Scattergood reiterated a “buy” rating on shares of Markel in a report on Thursday, October 26th. Finally, Zacks Investment Research downgraded shares of Markel from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $1,066.67.
Shares of Markel (MKL) traded up $12.13 during mid-day trading on Friday, hitting $1,139.13. 31,791 shares of the stock traded hands, compared to its average volume of 39,053. The stock has a market capitalization of $15,656.17, a P/E ratio of 253.14 and a beta of 1.05. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.55 and a current ratio of 0.55. Markel has a 52 week low of $887.40 and a 52 week high of $1,157.30.
In related news, Director Lemuel E. Lewis acquired 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The stock was acquired at an average price of $1,080.96 per share, for a total transaction of $1,080,960.00. Following the completion of the acquisition, the director now owns 5,294 shares of the company’s stock, valued at approximately $5,722,602.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Steven A. Markel sold 200 shares of the firm’s stock in a transaction dated Thursday, December 21st. The stock was sold at an average price of $1,132.73, for a total transaction of $226,546.00. Following the sale, the insider now owns 107,210 shares of the company’s stock, valued at approximately $121,439,983.30. The disclosure for this sale can be found here. Insiders have sold 2,307 shares of company stock valued at $2,523,756 in the last 90 days. 2.53% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of MKL. Vanguard Group Inc. increased its holdings in Markel by 2.6% during the second quarter. Vanguard Group Inc. now owns 1,129,189 shares of the insurance provider’s stock worth $1,101,931,000 after buying an additional 28,104 shares during the last quarter. Archford Capital Strategies LLC boosted its position in Markel by 34,592.5% during the second quarter. Archford Capital Strategies LLC now owns 13,877 shares of the insurance provider’s stock worth $204,000 after purchasing an additional 13,837 shares during the period. Janus Henderson Group PLC boosted its position in Markel by 712.3% during the second quarter. Janus Henderson Group PLC now owns 14,703 shares of the insurance provider’s stock worth $14,347,000 after purchasing an additional 12,893 shares during the period. Renaissance Technologies LLC boosted its position in Markel by 7.9% during the second quarter. Renaissance Technologies LLC now owns 167,577 shares of the insurance provider’s stock worth $163,532,000 after purchasing an additional 12,296 shares during the period. Finally, Thompson Siegel & Walmsley LLC boosted its position in Markel by 26.9% during the second quarter. Thompson Siegel & Walmsley LLC now owns 47,195 shares of the insurance provider’s stock worth $46,055,000 after purchasing an additional 10,014 shares during the period. Institutional investors and hedge funds own 76.79% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “$1.58 Billion in Sales Expected for Markel Co. (MKL) This Quarter” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2018/01/14/1-58-billion-in-sales-expected-for-markel-co-mkl-this-quarter.html.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Get a free copy of the Zacks research report on Markel (MKL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.